Chikungunya Virus and Its Envelope Protein E2 Induce Hyperalgesia in Mice: Inhibition by Anti-E2 Monoclonal Antibodies and by Targeting TRPV1
Cells · 2023
DOI: 10.3390/cells12040556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Carina Z Segato-Vendrameto und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina 86057-970, PR, Brazil. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Chikungunya virus, Hyperalgesia, Viral Envelope Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brazilian grants from the Coordination for the Improvement of Higher Education Personnel, National Council for Scientific and Technological Development, Department of Science and Technology from the Science, Technology and Strategic Inputs Secretariat of the Ministry of Health (Decit/SCTIE/MS, Brazil) intermedi….
Abstract (Originalsprache)
Chikungunya virus is an arthropod-borne infectious agent that causes Chikungunya fever disease. About 90% of the infected patients experience intense polyarthralgia, affecting mainly the extremities but also the large joints such as the knees. Chronic disease symptoms persist for months, even after clearance of the virus from the blood. Envelope proteins stimulate the immune response against the Chikungunya virus, becoming an important therapeutic target. We inactivated the Chikungunya virus (iCHIKV) and produced recombinant E2 (rE2) protein and three different types of anti-rE2 monoclonal antibodies. Using these tools, we observed that iCHIKV and rE2 protein induced mechanical hyperalgesia (electronic aesthesiometer test) and thermal hyperalgesia (Hargreaves test) in mice. These behavioral results were accompanied by the activation of dorsal root ganglia (DRG) neurons in mice, as observed by calcium influx. Treatment with three different types of anti-rE2 monoclonal antibodies and absence or blockade (AMG-9810 treatment) of transient receptor potential vanilloid 1 (TRPV1) channel diminished mechanical and thermal hyperalgesia in mice. iCHIKV and rE2 activated TRPV1+ mouse DRG neurons in vitro, demonstrating their ability to activate nociceptor sensory neurons directly. Therefore, our mouse data demonstrate that targeting E2 CHIKV protein with monoclonal antibodies and inhibiting TRPV1 channels are reasonable strategies to control CHIKV pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pain, Inflammation, Neuropathy, and Cancer, Department of Pathology, Londrina State University, Londrina 86057-970, PR, Brazil.
- Laboratory of Molecular Virology, Carlos Chagas Institute/Fiocruz PR, Curitiba 81310-020, PR, Brazil.
- Division of Dermatology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Center for Research in Health Sciences, University of Northern Paraná, Londrina 86041-140, PR, Brazil.
- Department of Pharmaceutical Sciences, University Hospital (Health Science Centre), Londrina State University, Londrina 86057-970, PR, Brazil.
- Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, 1 Blackfan Circle, Karp Research Building 11.006C, Boston, MA 02115, USA.
ORCID-Profile: Camila Zanluca, Tiago H Zaninelli, Mariana M Bertozzi, Camila R Ferraz, Stephanie Badaro-Garcia, Amanda M Dionisio, Sergio M Borghi, Juliano Bordignon, Victor Fattori, Claudia N Duarte Dos Santos, Waldiceu A Verri
Förderung
- Brazilian grants from the Coordination for the Improvement of Higher Education Personnel
- National Council for Scientific and Technological Development
- Department of Science and Technology from the Science, Technology and Strategic Inputs Secretariat of the Ministry of Health (Decit/SCTIE/MS, Brazil) intermedi…
- Support Program for Excellence Groups (PRONEX) grant supported by SETI/Araucaria Foundation and MCTI/CNPq; and Paraná State Government
- CMLP-UEL (Central Multiuser de Laboratorios de Pesquisa—Universidade Estadual de Londrina)
- CAPES fellowships
- FUNADESP fellowship
- Senior Research CNPq fellowship
Zitieren
APA
Segato-Vendrameto, C. Z., Zanluca, C., Zucoloto, A. Z., Zaninelli, T. H., Bertozzi, M. M., Saraiva-Santos, T., Ferraz, C. R., Staurengo-Ferrari, L., Badaro-Garcia, S., Manchope, M. F., Dionisio, A. M., Pinho-Ribeiro, F. A., Borghi, S. M., Mosimann, A. L. P., Casagrande, R., Bordignon, J., Fattori, V., Santos, C. N. D. D., & Verri, W. A. (2023). Chikungunya Virus and Its Envelope Protein E2 Induce Hyperalgesia in Mice: Inhibition by Anti-E2 Monoclonal Antibodies and by Targeting TRPV1. Cells. https://doi.org/10.3390/cells12040556
Vancouver
Segato-Vendrameto CZ, Zanluca C, Zucoloto AZ, Zaninelli TH, Bertozzi MM, Saraiva-Santos T, et al. Chikungunya Virus and Its Envelope Protein E2 Induce Hyperalgesia in Mice: Inhibition by Anti-E2 Monoclonal Antibodies and by Targeting TRPV1. Cells. 2023. doi:10.3390/cells12040556
BibTeX
@article{SegatoVendrameto2023,
author = {Segato-Vendrameto, Carina Z and Zanluca, Camila and Zucoloto, Amanda Z and Zaninelli, Tiago H and Bertozzi, Mariana M and Saraiva-Santos, Telma and Ferraz, Camila R and Staurengo-Ferrari, Larissa and Badaro-Garcia, Stephanie and Manchope, Marília F and Dionisio, Amanda M and Pinho-Ribeiro, Felipe A and Borghi, Sergio M and Mosimann, Ana Luiza Pamplona and Casagrande, Rubia and Bordignon, Juliano and Fattori, Victor and Santos, Claudia N Duarte Dos and Verri, Waldiceu A},
title = {Chikungunya Virus and Its Envelope Protein E2 Induce Hyperalgesia in Mice: Inhibition by Anti-E2 Monoclonal Antibodies and by Targeting TRPV1},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12040556}
}
EUVIMED